Decreased corticosensitivity in quiescent Crohn's disease: an ex vivo study using whole blood cell cultures
- PMID: 10389698
- DOI: 10.1023/a:1026644711530
Decreased corticosensitivity in quiescent Crohn's disease: an ex vivo study using whole blood cell cultures
Abstract
Corticosensitivity influences the degree and the duration of an inflammatory reaction by altering target cell responses to endogenous and/or exogenous glucocorticoids. Indeed, different clinical responses to glucocorticoids have been observed among patients with Crohn's disease, suggesting different degrees of corticosensitivity in these subjects. The purpose of this study was to compare the corticosensitivity of patients with quiescent Crohn's disease to that of healthy subjects (HS). Nineteen patients with quiescent Crohn's disease and 14 HS were studied; all patients were steroid-free for at least six months; 7 of the 19 were corticosteroid-dependent (CSD) and treated with nonglucocorticoid immunosuppressants at the time of the study. Corticosensitivity was measured by the inhibition of LPS-induced cytokine secretion in whole blood cell cultures treated with increasing concentrations (10(-9) to 10(-6) M) of dexamethasone. Tumor-necrosis factor-alpha (TNF-alpha), interleukin-6 (IL-6), and interleukin-1 beta (IL-1 beta) were measured using specific immunoassays. Crohn's disease patients had a markedly decreased dexamethasone-mediated inhibition of TNF-alpha (P < 0.01), IL-6 (P < 0.001), and IL-1 beta (P < 0.01) compared to healthy subjects, with a shift of the dexamethasone dose-response curve to the right. No significant differences in the basal and LPS-stimulated secretion of the three cytokines were observed between CSD and non-CSD patients, and both subgroups of patients had similar degrees of dexamethasone-mediated cytokine inhibition. We conclude that patients with Crohn's disease have a significant decrease in the corticosensitivity of their leukocytes. This may be related to a specific genetic/constitutional background and/or could be acquired, due to inflammation-related endocrine and/or immune factors.
Similar articles
-
Tumor necrosis factor alpha decreases, and interleukin-10 increases, the sensitivity of human monocytes to dexamethasone: potential regulation of the glucocorticoid receptor.J Clin Endocrinol Metab. 1999 Aug;84(8):2834-9. doi: 10.1210/jcem.84.8.5931. J Clin Endocrinol Metab. 1999. PMID: 10443688
-
Levels of portal and systemic blood cytokines after colectomy in patients with carcinoma or Crohn's disease.J Am Coll Surg. 1995 Jun;180(6):718-24. J Am Coll Surg. 1995. PMID: 7773486
-
LPS-Stimulated Whole Blood Cytokine Production Is Not Related to Disease Behavior in Patients with Quiescent Crohn's Disease.PLoS One. 2015 Jul 24;10(7):e0133932. doi: 10.1371/journal.pone.0133932. eCollection 2015. PLoS One. 2015. PMID: 26208333 Free PMC article.
-
Effects of dexamethasone on the profile of cytokine secretion in human whole blood cell cultures.Regul Pept. 1998 Jan 2;73(1):59-65. doi: 10.1016/s0167-0115(97)01063-x. Regul Pept. 1998. PMID: 9537674
-
Increased production of tumour necrosis factor-alpha interleukin-1 beta, and interleukin-6 by morphologically normal intestinal biopsies from patients with Crohn's disease.Gut. 1996 Nov;39(5):684-9. doi: 10.1136/gut.39.5.684. Gut. 1996. PMID: 9026483 Free PMC article.
Cited by
-
Steroid-induced ocular hypertension/glaucoma: Focus on pharmacogenomics and implications for precision medicine.Prog Retin Eye Res. 2017 Jan;56:58-83. doi: 10.1016/j.preteyeres.2016.09.003. Epub 2016 Sep 22. Prog Retin Eye Res. 2017. PMID: 27666015 Free PMC article. Review.
-
In vitro sensitivity assays and clinical response to glucocorticoids in patients with inflammatory bowel disease.J Crohns Colitis. 2014 Nov;8(11):1539-47. doi: 10.1016/j.crohns.2014.06.013. Epub 2014 Jul 19. J Crohns Colitis. 2014. PMID: 25052346 Free PMC article.
-
Glucocorticoid sensitivity in health and disease.Nat Rev Endocrinol. 2013 Nov;9(11):670-86. doi: 10.1038/nrendo.2013.183. Epub 2013 Oct 1. Nat Rev Endocrinol. 2013. PMID: 24080732 Review.
-
Interferon-inducible factor 16 is a novel modulator of glucocorticoid action.FASEB J. 2010 Jun;24(6):1700-13. doi: 10.1096/fj.09-139998. Epub 2010 Jan 19. FASEB J. 2010. PMID: 20086048 Free PMC article.
-
Macroscopic, microscopic and biochemical characterisation of spontaneous colitis in a transgenic mouse, deficient in the multiple drug resistance 1a gene.Br J Pharmacol. 2004 Nov;143(5):590-8. doi: 10.1038/sj.bjp.0705982. Epub 2004 Oct 4. Br J Pharmacol. 2004. PMID: 15466445 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical